Here, we used CRISPR genome-editing technology and demonstrated that disruption of the PTPRZ gene in human glioma LN-229 cells resulted in profoundly reduced tumor growth in xenografted mice, suggesting that PTPRZ may be a potential therapeutic target for glioma. The gene discussed is PTPRZ1; the disease is neoplasm.